Telavancin Observational Use Registry (TOUR)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2017
At a glance
- Drugs Telavancin (Primary)
- Indications Bacteraemia; Bone and joint infections; Endocarditis; Gram-positive infections; Nosocomial pneumonia; Skin and soft tissue infections
- Focus Therapeutic Use
- Acronyms TOUR
- Sponsors Theravance Biopharma
- 09 Oct 2017 According to a Theravance Biopharma media release, preliminary data from the study has been presented at IDWeek™ 2017.
- 09 Oct 2017 According to a Theravance Biopharma media release, the company plans to present additional collections of data from the study at appropriate upcoming scientific conferences.
- 09 Oct 2017 Results presented in a Theravance Biopharma media release.